G-CSF and liver toxicity in a patient with neuroblastoma
- 28 November 1992
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 340 (8831) , 1352
- https://doi.org/10.1016/0140-6736(92)92535-n
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Lactate dehydrogenase changes during granulocyte colony-stimulating factor treatmentThe Lancet, 1992
- Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapyThe American Journal of Medicine, 1990
- Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.Journal of Clinical Oncology, 1989
- Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancyBlood, 1989
- Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy.Journal of Clinical Oncology, 1989
- EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPYThe Lancet, 1988